The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

Mannatech settles Texas lawsuit

 Feb 27, 2009 04:45 PM UTC
Return Risk
-8.88% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
MTEX n/a

Graphic_arrow1 Via BloggingStocks:  

Filed under: Law, Scandals

Mannatech (NASDAQ: MTEX), that ever-sleazy multi-level marketing company specializing in the sale of miracle pills, has settled a lawsuit with the Texas Attorney General involving the company's marketing practices.

Mannatech will pay $4 million in restitution to customers and $2 million to the state to cover its investigation expenses. Sam Caster, the company's founder, former chairman, and largest shareholders, will also pay $1 million and be barred from serving as an employee, officer, or director of the company for five years.

In 2007, Texas' attorney general filed a lawsuit accusing the company of exaggerating the benefits of its products, based on marketing materials produced by the company's independent distributors, which claimed that Mannatech vitamins could cure cancer and down syndrome.

Shares of Mannatech still trade on the NASDAQ for around $3 per share. In a press release, the company's CEO said that Mannatech has made significant changes to its operations since the investigation began, including the devotion of more resources to monitoring distributor compliance. But the fact is that Mannatech sells an overpriced product through a multi-level marketing structure that is rife with potential for consumer abuse.

Mannatech settles Texas lawsuit originally appeared on BloggingStocks on Fri, 27 Feb 2009 11:45:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati



 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch